drugset / Trial / NCT05914545
A Study of FZ-AD004 in Patients With Advanced Solid Tumors
NaSequentialOpen-labelTreatment
Summary
This study is one single group of participants with advanced solid tumors. It is the first time the drug has been used in humans. There will be two parts including Dose Escalation and Dose Expansion to evaluate the safety, tolerability, pharmacokinetics, and clinical activity of FZ-AD004.
Timeline
- Start
- 2023-06-12
- Primary completion
- 2026-12
- Completion
- 2027-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | FZ-AD004 | Unknown | — | Intravenous |
Indications
No indication recorded.